AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE Trademark
Serial Number: 99358160
AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE is a trademark filed by
Seqirus Inc.
on August 26, 2025. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently pending registration.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Nancy Sabarra Fross Zelnick Lehrman & Zissu, P.C.
151 West 42nd St., 17th Fl.
New York, NY 10036
United States
Trademark Details
Filing Date
August 26, 2025
Registration Date
Not Registered
Published for Opposition
February 17, 2026
Goods & Services
Vaccines
Filing History
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 22, 2026 EXRA
SOU EXTENSION 1 GRANTED
May 21, 2026 EX1G
SOU EXTENSION 1 FILED
May 21, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
May 21, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 14, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 17, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 17, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 11, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 22, 2026 CNSA
ASSIGNED TO EXAMINER
Jan 19, 2026 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 18, 2026 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 18, 2026 NWOS
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Sep 22, 2025 AMPX
ASSIGNED TO LIE
Sep 16, 2025 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Sep 9, 2025 PARI
APPLICATION FILING RECEIPT MAILED
Aug 26, 2025 MAFR
NEW APPLICATION ENTERED
Aug 26, 2025 NWAP
